↓ Skip to main content

Sigma Receptors: Their Role in Disease and as Therapeutic Targets

Overview of attention for book
Cover of 'Sigma Receptors: Their Role in Disease and as Therapeutic Targets'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction to Sigma Receptors: Their Role in Disease and as Therapeutic Targets
  3. Altmetric Badge
    Chapter 2 Structural Perspectives on Sigma-1 Receptor Function
  4. Altmetric Badge
    Chapter 3 A Review of the Human Sigma-1 Receptor Structure
  5. Altmetric Badge
    Chapter 4 Fluorinated PET Tracers for Molecular Imaging of σ1 Receptors in the Central Nervous System
  6. Altmetric Badge
    Chapter 5 The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target
  7. Altmetric Badge
    Chapter 6 Sigma 1 Receptor and Ion Channel Dynamics in Cancer
  8. Altmetric Badge
    Chapter 7 Sigma-1 Receptors Fine-Tune the Neuronal Networks
  9. Altmetric Badge
    Chapter 8 Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain
  10. Altmetric Badge
    Chapter 9 Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics
  11. Altmetric Badge
    Chapter 10 Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection
  12. Altmetric Badge
    Chapter 11 Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders
  13. Altmetric Badge
    Chapter 12 Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease
  14. Altmetric Badge
    Chapter 13 Sigma Receptors and Substance Use Disorders
  15. Altmetric Badge
    Chapter 14 Stimulation of the Sigma-1 Receptor and the Effects on Neurogenesis and Depressive Behaviors in Mice
  16. Altmetric Badge
    Chapter 15 Role of σ1 Receptors in Learning and Memory and Alzheimer’s Disease-Type Dementia
  17. Altmetric Badge
    Chapter 16 Sigma-1 Receptor in Motoneuron Disease
  18. Altmetric Badge
    Chapter 17 The Sigma-1 Receptor–A Therapeutic Target for the Treatment of ALS?
  19. Altmetric Badge
    Chapter 18 The Role of Sigma1R in Mammalian Retina
  20. Altmetric Badge
    Chapter 19 Peeking into Sigma-1 Receptor Functions Through the Retina
  21. Altmetric Badge
    Chapter 20 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Attention for Chapter 5: The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target
Chapter number 5
Book title
Sigma Receptors: Their Role in Disease and as Therapeutic Targets
Published in
Advances in experimental medicine and biology, March 2017
DOI 10.1007/978-3-319-50174-1_5
Pubmed ID
Book ISBNs
978-3-31-950172-7, 978-3-31-950174-1
Authors

Chenbo Zeng, Robert H. Mach, Zeng, Chenbo, Mach, Robert H.

Editors

Sylvia B. Smith, Tsung-Ping Su

Abstract

The sigma-2 (σ2) receptor represents one of the most poorly understood proteins in cell biology. Although this receptor was identified through in vitro binding studies over 25 years ago, the molecular identity of this protein is currently not unambiguously known, and the results from recent attempts to identify the σ2 receptor through protein purification and mass spectral analysis have been the subject of debate in the literature. However, there is overwhelming data demonstrating that the σ2 receptor is an important biomarker of tumor cell proliferation . The observation that σ2 receptor agonists are potent anticancer agents whereas σ2 antagonists block Aβ1-42 oligomer synaptic dysfunction in transgenic mouse models of Alzheimer's disease have clearly identified this protein as an important therapeutic target for the treatment of a variety of pathological conditions.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 13%
Student > Ph. D. Student 2 13%
Researcher 2 13%
Lecturer 1 6%
Professor 1 6%
Other 3 19%
Unknown 5 31%
Readers by discipline Count As %
Chemistry 3 19%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Chemical Engineering 1 6%
Computer Science 1 6%
Other 3 19%
Unknown 6 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2017.
All research outputs
#4,210,343
of 22,961,203 outputs
Outputs from Advances in experimental medicine and biology
#696
of 4,958 outputs
Outputs of similar age
#81,613
of 334,647 outputs
Outputs of similar age from Advances in experimental medicine and biology
#4
of 77 outputs
Altmetric has tracked 22,961,203 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,958 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,647 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.